S&P 500   3,281.47 (-3.22%)
DOW   26,576.37 (-3.23%)
QQQ   273.15 (-3.36%)
AAPL   112.39 (-3.61%)
MSFT   204.49 (-4.11%)
FB   269.88 (-4.73%)
GOOGL   1,519.27 (-4.98%)
AMZN   3,179.00 (-3.27%)
TSLA   409.91 (-3.48%)
NVDA   513.61 (-4.15%)
BABA   306.90 (-3.23%)
CGC   18.57 (-0.48%)
GE   7.77 (+9.44%)
MU   50.02 (-3.73%)
AMD   76.86 (-2.56%)
T   26.54 (-1.41%)
F   7.71 (-2.65%)
ACB   3.90 (-2.50%)
GILD   58.56 (-2.42%)
NFLX   486.21 (-0.56%)
NIO   27.22 (-4.29%)
BA   150.07 (-3.33%)
DIS   119.44 (-3.14%)
S&P 500   3,281.47 (-3.22%)
DOW   26,576.37 (-3.23%)
QQQ   273.15 (-3.36%)
AAPL   112.39 (-3.61%)
MSFT   204.49 (-4.11%)
FB   269.88 (-4.73%)
GOOGL   1,519.27 (-4.98%)
AMZN   3,179.00 (-3.27%)
TSLA   409.91 (-3.48%)
NVDA   513.61 (-4.15%)
BABA   306.90 (-3.23%)
CGC   18.57 (-0.48%)
GE   7.77 (+9.44%)
MU   50.02 (-3.73%)
AMD   76.86 (-2.56%)
T   26.54 (-1.41%)
F   7.71 (-2.65%)
ACB   3.90 (-2.50%)
GILD   58.56 (-2.42%)
NFLX   486.21 (-0.56%)
NIO   27.22 (-4.29%)
BA   150.07 (-3.33%)
DIS   119.44 (-3.14%)
S&P 500   3,281.47 (-3.22%)
DOW   26,576.37 (-3.23%)
QQQ   273.15 (-3.36%)
AAPL   112.39 (-3.61%)
MSFT   204.49 (-4.11%)
FB   269.88 (-4.73%)
GOOGL   1,519.27 (-4.98%)
AMZN   3,179.00 (-3.27%)
TSLA   409.91 (-3.48%)
NVDA   513.61 (-4.15%)
BABA   306.90 (-3.23%)
CGC   18.57 (-0.48%)
GE   7.77 (+9.44%)
MU   50.02 (-3.73%)
AMD   76.86 (-2.56%)
T   26.54 (-1.41%)
F   7.71 (-2.65%)
ACB   3.90 (-2.50%)
GILD   58.56 (-2.42%)
NFLX   486.21 (-0.56%)
NIO   27.22 (-4.29%)
BA   150.07 (-3.33%)
DIS   119.44 (-3.14%)
S&P 500   3,281.47 (-3.22%)
DOW   26,576.37 (-3.23%)
QQQ   273.15 (-3.36%)
AAPL   112.39 (-3.61%)
MSFT   204.49 (-4.11%)
FB   269.88 (-4.73%)
GOOGL   1,519.27 (-4.98%)
AMZN   3,179.00 (-3.27%)
TSLA   409.91 (-3.48%)
NVDA   513.61 (-4.15%)
BABA   306.90 (-3.23%)
CGC   18.57 (-0.48%)
GE   7.77 (+9.44%)
MU   50.02 (-3.73%)
AMD   76.86 (-2.56%)
T   26.54 (-1.41%)
F   7.71 (-2.65%)
ACB   3.90 (-2.50%)
GILD   58.56 (-2.42%)
NFLX   486.21 (-0.56%)
NIO   27.22 (-4.29%)
BA   150.07 (-3.33%)
DIS   119.44 (-3.14%)
Log in
NYSE:LH

Laboratory Co. of America Stock Forecast, Price & News

$204.63
-1.86 (-0.90 %)
(As of 10/28/2020 01:03 PM ET)
Add
Compare
Today's Range
$201.94
Now: $204.63
$208.00
50-Day Range
$173.73
MA: $189.68
$207.49
52-Week Range
$98.02
Now: $204.63
$212.47
Volume13,791 shs
Average Volume907,063 shs
Market Capitalization$19.93 billion
P/E Ratio55.76
Dividend YieldN/A
Beta1.25
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular and infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other procedures. In addition, it provides a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, and QIAGEN N.V; and Ciox Health for the creation of COVID-19 patient data registry in the United States. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Read More
Laboratory Co. of America logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.30 out of 5 stars

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127
Employees65,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.55 billion
Cash Flow$19.91 per share
Book Value$77.93 per share

Profitability

Net Income$823.80 million

Miscellaneous

Market Cap$19.93 billion
Next Earnings Date2/11/2021 (Estimated)
OptionableOptionable
$204.63
-1.86 (-0.90 %)
(As of 10/28/2020 01:03 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Laboratory Co. of America (NYSE:LH) Frequently Asked Questions

How has Laboratory Co. of America's stock been impacted by COVID-19?

Laboratory Co. of America's stock was trading at $158.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, LH shares have increased by 28.5% and is now trading at $204.29.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Laboratory Co. of America?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last year. There are currently 1 hold rating and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Laboratory Co. of America
.

When is Laboratory Co. of America's next earnings date?

Laboratory Co. of America is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Laboratory Co. of America
.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) released its earnings results on Tuesday, October, 27th. The medical research company reported $8.41 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $5.29 by $3.12. The medical research company earned $3.90 billion during the quarter, compared to analyst estimates of $3.62 billion. Laboratory Co. of America had a return on equity of 14.39% and a net margin of 3.16%. Laboratory Co. of America's revenue for the quarter was up 33.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.90 earnings per share.
View Laboratory Co. of America's earnings history
.

What price target have analysts set for LH?

16 equities research analysts have issued 1 year price targets for Laboratory Co. of America's stock. Their forecasts range from $170.00 to $260.00. On average, they anticipate Laboratory Co. of America's share price to reach $225.19 in the next twelve months. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for Laboratory Co. of America
.

Are investors shorting Laboratory Co. of America?

Laboratory Co. of America saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 1,550,000 shares, an increase of 24.0% from the September 30th total of 1,250,000 shares. Based on an average trading volume of 708,100 shares, the short-interest ratio is currently 2.2 days. Currently, 1.6% of the shares of the company are sold short.
View Laboratory Co. of America's Short Interest
.

Who are some of Laboratory Co. of America's key competitors?

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA), Abbott Laboratories (abt), AbbVie (ABBV), Alibaba Group (BABA) and Amgen (AMGN).

Who are Laboratory Co. of America's key executives?

Laboratory Co. of America's management team includes the following people:
  • Mr. Adam H. Schechter, Pres, CEO & Chairman (Age 55, Pay $1.79M)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 59, Pay $1.46M)
  • Mr. Lance V. Berberian, Exec. VP and Chief Information & Technology Officer (Age 57, Pay $876.62k)
  • Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH, Exec. VP, Pres of Diagnostics & Chief Medical Officer (Age 46, Pay $3.36M)
  • Mr. Mark S. Schroeder, Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain (Age 59, Pay $3.19M)

What is Laboratory Co. of America's stock symbol?

Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Co. of America's major shareholders?

Laboratory Co. of America's stock is owned by many different retail and institutional investors. Top institutional shareholders include LSV Asset Management (0.34%), AMI Asset Management Corp (0.32%), Hunter Perkins Capital Management LLC (0.23%), Candriam Luxembourg S.C.A. (0.22%), Bartlett & Co. LLC (0.18%) and KBC Group NV (0.17%). Company insiders that own Laboratory Co. of America stock include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Jean-Luc Belingard, Judith C Seltz, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Peter J Wilkinson, R Sanders Williams and Robert E Mittelstaedt Jr.
View institutional ownership trends for Laboratory Co. of America
.

Which institutional investors are selling Laboratory Co. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Hahn Capital Management LLC, Retirement Systems of Alabama, AMI Asset Management Corp, Hunter Perkins Capital Management LLC, Calamos Wealth Management LLC, State of Alaska Department of Revenue, Franklin Street Advisors Inc. NC, and Standard Life Aberdeen plc. Company insiders that have sold Laboratory Co. of America company stock in the last year include David P King, Der Vaart Sandra D Van, Jean-Luc Belingard, Mark S Schroeder, Peter J Wilkinson, and R Sanders Williams.
View insider buying and selling activity for Laboratory Co. of America
.

Which institutional investors are buying Laboratory Co. of America stock?

LH stock was bought by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, KBC Group NV, DNB Asset Management AS, Alberta Investment Management Corp, Envestnet Asset Management Inc., Candriam Luxembourg S.C.A., M&G Investment Management Ltd., and Sequoia Financial Advisors LLC.
View insider buying and selling activity for Laboratory Co. of America
.

How do I buy shares of Laboratory Co. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Laboratory Co. of America's stock price today?

One share of LH stock can currently be purchased for approximately $204.29.

How big of a company is Laboratory Co. of America?

Laboratory Co. of America has a market capitalization of $19.90 billion and generates $11.55 billion in revenue each year. The medical research company earns $823.80 million in net income (profit) each year or $11.32 on an earnings per share basis. Laboratory Co. of America employs 65,000 workers across the globe.

What is Laboratory Co. of America's official website?

The official website for Laboratory Co. of America is www.labcorp.com.

How can I contact Laboratory Co. of America?

Laboratory Co. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]

This page was last updated on 10/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.